EC[ON]OMY

Closing the gender health gap in Canada: a $37 billion solution

Over the past two centuries, life expectancy in Canada has more than doubled-from 40 to nearly 82 years. But according to the McKinsey Health Institute, this impressive milestone hides a troubling reality: Canadian women live longer, yet spend 24% more time in poor health than men. On average, women live 14 years with illness or disability compared to 11 years for men.

This is more than a medical issue-it’s an economic one. McKinsey estimates that if Canada were to close its women’s health gap, the economy could gain up to $37 billion annually by 2040. That’s roughly equivalent to the entire annual output of Canada’s agricultural sector.

Canada ranks among the world’s top ten countries for gender equality, but when it comes to health, it performs poorly-fifth worst among major economies in GDP losses linked to gender health disparities. The problem isn’t a lack of resources, but rather misplaced priorities.

McKinsey’s analysis shows that women’s health issues go far beyond reproductive care, which accounts for just 5% of the total burden. The majority comes from heart disease, cancer, and neurological conditions, which together represent 75% of the overall health gap between women and men.

McKinsey’s model translates years of poor health into lost economic value. The economic opportunity from closing the gap comes through four main channels:

•  fewer chronic illnesses;

•  higher female participation in the labor force;

•  greater productivity;

•  fewer premature deaths.

Altogether, this could generate $37 billion per year in additional GDP: $16.1 billion from higher productivity, $10.5 billion from greater participation, $7 billion from improved health, and $4.2 billion from reduced premature mortality.

For comparison, McKinsey’s own analysis of AI in healthcare estimated potential savings of $14–26 billion. The women’s health gap represents an even greater opportunity-larger, more sustainable, and deeply human.

About one-third of the total impact comes from just ten conditions-chief among them depression, migraine, premenstrual syndrome (PMS), osteoarthritis, and gynecological disorders. The first three alone-PMS, depression, and migraine-cost the economy more than $6 billion annually.

Regional differences are striking. Ontario and Quebec together account for more than $20 billion of potential GDP growth. Alberta and Saskatchewan could add another $7.5 billion. In Canada’s northern and Atlantic provinces, the focus is less on sheer economic gain and more on equitable access to care-a vital part of closing the gap nationwide.

McKinsey identifies three main drivers of inequality.

The first is the efficacy gap. Medical research has historically been based on male biology, leaving women underrepresented in clinical trials. As a result, female symptoms are often misunderstood or misdiagnosed-78% of early heart attack signs in women go unrecognized. Women are also 30% more likely to seek emergency care for asthma, yet treatments are still based on “male” standards.

The second is the access gap. Women in rural areas, immigrants, and Indigenous populations face major barriers to care. Infant mortality in Indigenous communities is more than twice the national rate, and menopause symptoms-long underestimated-continue to reduce productivity and well-being.

The third is the data gap. Even in Canada, where Health Canada launched the Sex- and Gender-Based Analysis Plus (2022–2026)initiative, the system still lacks consistent, disaggregated health data. Without it, policymakers and researchers can’t see the full picture or design effective interventions.

To address these challenges, McKinsey proposes 14 key actions-spanning healthcare, business, and policy. Among them:

•  a new national strategy on women’s health;

•  interprovincial coalitions to share best practices;

•  education for doctors on sex-based differences in diagnosis and treatment;

•  support for femtech startups and innovation;

•  corporate programs tailored to women’s health and work-life balance;

•  targeted investment and philanthropy focused on women’s well-being.

Roughly 75% of the economic benefits and half of the gains in healthy life expectancy occur during working age. Women make up 75% of Canada’s teachers, 90% of nurses, and the majority of caregivers-meaning that improving their health strengthens the entire foundation of human capital.

Canada’s experience shows that investing in women’s health is not just a social policy-it’s an economic growth strategy. For Kazakhstan, where similar barriers exist-regional inequality, limited preventive care, and scarce gender-specific data-the lesson is clear: Improving women’s health can boost GDP, expand the tax base, and raise productivity. As in Canada, health equality could become a cornerstone of Kazakhstan’s economic modernization, where women’s well-being is viewed not as an expense, but as a national investment in prosperity.

The gender health gap is more than an issue of fairness-it’s an invisible economic leak that costs billions every year. Closing it could give every Canadian woman an extra week of healthy life annually-and an economy operating at its full potential.

Women’s health is no longer a niche medical concern. It is the new frontier of economic competitiveness in the 21st century.

Alen Serik, expert of the  portal EconomyKZ.org

Scroll to Top